Tobias Otto

5PUBLICATIONS
13CO-AUTHORS
Haematological tumoursPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 24, 2023
Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice.

Julia Otto, Anna Verwaayen, Christian Penners

|Aug 13, 2022
ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression.

Julia Grube, Marius Maximilian Woitok, Antje Mohs

|Jan 21, 2022
NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease.

Rebecca Elena Mainz, Stefanie Albers, Madhuri Haque

|Feb 04, 2021
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.

Navid Sobhani, Anne Fassl, Giuseppina Mondani

|Sep 20, 2017
Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit.

Tobias Otto, Sheyla V Candido, Mary S Pilarz

Pageof 1

Frequent Collaborators

2 joint publications

Christian Trautwein

1 joint publications

Navid Sobhani

1 joint publications

Daniele Generali

1 joint publications

Stefanie Albers